An2 Therapeutics shares owned by Octagon Capital Advisors
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Octagon Capital Advisors
from 13F filings
Historical chart of Octagon Capital Advisors investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Octagon Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $14M | 665k | 20.49 |
| 2023-09-30 | $14M | 868k | 16.08 |
| 2023-06-30 | $6.1M | 721k | 8.50 |